Inge van der Werf

Years Active: 2021-2021
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Inge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, Rocco Sciarrillo, Manja Meggendorfer, Stephan Hutter, Wencke Walter, Jeroen Janssen, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, Gerrit Jansen, Gertjan J L Kaspers, Richard Groen, Gert Ossenkoppele, Jacqueline Cloos
SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia. Leukemia 35 (9) (2021)
Anna Wojtuszkiewicz, Inge van der Werf, Stephan Hutter, Wencke Walter, Constance Baer, Wolfgang Kern, Jeroen J W M Janssen, Gert J Ossenkoppele, Claudia Haferlach, Jacqueline Cloos, Torsten Haferlach
Maturation State-Specific Alternative Splicing in FLT3-ITD and NPM1 Mutated AML. Cancers 13 (16) (2021)
Inge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, Stephan Hutter, Constance Baer, Martijn Heymans, Peter J M Valk, Wolfgang Kern, Claudia Haferlach, Jeroen J W M Janssen, Gert J Ossenkoppele, Jacqueline Cloos, Torsten Haferlach
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification. Blood advances 5 (17) (2021)
Joost B Koedijk, Inge van der Werf, Friso G J Calkoen, Stefan Nierkens, Gertjan J L Kaspers, Christian Michel Zwaan, Olaf Heidenreich
Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward. Cancers 13 (17) (2021)

Inge van der Werf.css-eqlu8i{font-size:small;padding-left:4px;}